ZENITHDRUG logo

Zenith Drugs Limited

ZENITHDRUG·NSE·
41.00 -1.10 (-2.61%)
Market Cap70.74 Cr
PE Ratio17.83
Volume9,600
Day High - Low41.40 - 41.00
52W High-Low73.45 - 33.30
DocStoX Score
5.0/10
Weak
Fair Value
Sign in to see
ROE
15.48%
Strong
P/E
17.83x
Fair
Debt / Equity
0.74
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day41.00
41.40
52W33.30
73.45
DocStoX take

Supported by valuation (9.0) and risk (6.4), but held back by momentum (0.6). Valuation looks strong at 9.0, but that is offset by momentum at 0.6. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.0
/10
Weak
Quality
Modest
ROE 15.5%
Valuation
Cheap
P/E 17.8×
Growth
Steady
Revenue +18.9% 5Y CAGR
Risk
Moderate
D/E 0.74
Momentum
Weak
19% of 52-week range

At a glance

Market Cap
₹71 Cr
52W High / Low
₹73 / ₹33
Dividend Yield
1.21%
Promoter Holding
69.98%
EPS (TTM)
₹2.30
Book Value
₹43.69

Key highlights

  • Profitable in all of the last 5 years
  • Revenue compounding 19% a year
  • Momentum is weak (0.6/10)
  • Near the bottom of its 52-week range (19%)
2 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

ZENITH DRUGS LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.